Pharma Journalist - Page 71 of 936 -

Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

ENHERTU Plus Pertuzumab Granted U.S. Breakthrough Therapy Status for HER2+ Metastatic Breast Cancer

AlzeCure’s ACD440 Pain Therapy Receives FDA Orphan Drug Designation

Sanofi’s SAR446597 Granted FDA Fast Track for Geographic Atrophy in AMD

Endeavor BioMedicines’ Taladegib Granted Orphan Drug Status in U.S. and EU for IPF

FDA Approves GSK’s Shingrix in Prefilled Syringe Format

Thermo Fisher and Sanofi Expand U.S. Drug Manufacturing Partnership

Repare Therapeutics Signs Exclusive Global License Deal with Debiopharm for Lunresertib

Boehringer Ingelheim and LEO Pharma Partner to Commercialize and Develop SPEVIGO

Vertex Secures NHS England Reimbursement for Once-Daily CFTR Modulator ALYFTREK

Otsuka Acquires Global Rights to Cantargia’s CAN10 for Autoimmune Disease Treatment